Table 3. Study population and published results for included trials.

Protocol	N	M/F (%)	PS 0/1/2 (%)	PFS	OS
ECOG-1298	32	50 / 50	12 / 72 / 16	2.1 Median PFS	4.7 mos Median OS
ECOG-2297 Arm 1	162	54 / 46	35 / 52 / 14	2.2 mos. Median PFS	5.4 mos. Median OS
ECOG-2297 Arm 2	160	52 / 48	23 / 64 / 14	3.4 mos Median PFS	6.7 mos Median OS
ECOG-3296	36	69 / 31	28 / 53 / 19	2.4 mos. Median TTF*	4.3 mos Median OS
NCCTG-0043	48	37 / 63	34 /58 / 8	3.8 mos. Median PFS	6.7 mos. Median OS
NCCTG-014C Arm B	36	53 / 47	35 / 58 / 7	2.4 mos.	4. 8 mos.
NCCTG-034A	82	70 / 27&	40 / 54 /6&	5.7 mos	8.1 mos.
NCCTG-984351	46	56 / 44	35/41 / 20	4.5 mos.	6.2 mos.
SWOG-0205 Arm 1	371	54 / 46	87 / 13#	3.0 mos.	5.9 mos.
SWOG-0205 Arm 2	372	51 / 49	87 / 13#	3.4 mos.	6.3 mos.

^*Time to treatment failure

^#PS 0-1 / 2

^&Percentages generated from data, not published report